¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"skin test agent"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • articulation test
    ¹ßÀ½°Ë»ç
  • association test
    ¿¬»ó°Ë»ç
  • achievement test
    ¼ºÃëµµ°Ë»ç
  • autohemolysis test
    ÀÚ°¡¿ëÇ÷°Ë»ç
  • acid challenge test
    »êÅõ¿©°Ë»ç
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å°Ë»ç
  • adsorption test
    ÈíÂø½ÃÇè, ºÎÂø°Ë»ç
  • afterimage test
    ÀÜ»ó°Ë»ç
  • agar gel precipitin inhibition test
    ¿ì¹«°Öħ°­¼Ò¾ïÁ¦°Ë»ç
  • agglutination test
    ÀÀÁý°Ë»ç
  • air conduction test
    °ø±âÀüµµ°Ë»ç
  • alkali denaturation test
    ¾ËÄ®¸®º¯¼º°Ë»ç
  • alternate cover test
    ±³´ë°¡¸²°Ë»ç
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • Ames test
    ¿¡ÀÓ½º°Ë»ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • spermicidal agent
    »ìÁ¤ÀÚÁ¦
  • therapeutic agent
    Ä¡·áÁ¦
  • toxic agent
    µ¶¹°, µ¶±Ø¹°
  • volatile agent
    Èֹ߼º¾à
  • volatile inhalation agent
    Èֹ߼ºÈíÀÔ¸¶ÃëÁ¦
  • single-agent chemotherapy
    ´ÜÀÏÁ¦Á¦Ç×¾ÏÈ­Çпä¹ý
  • abrasion test
    ¸¶¸ê½ÃÇè
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • acceptance test
    Àμö°Ë»ç
  • achievement test
    ¼ºÃëµµ°Ë»ç
  • acid challenge test
    »êÅõ¿©°Ë»ç
  • acid elution slide test
    »ê¿ëÃâ½½¶óÀ̵å°Ë»ç
  • adsorption test
    ÈíÂø½ÃÇè, ºÎÂø°Ë»ç
  • afterimage test
    ÀÜ»ó°Ë»ç
  • agar gel precipitin inhibition test
    ¿ì¹«°Öħ°­¼Ò¾ïÁ¦°Ë»ç
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • C-Stix test
    C-½ºÆ½½º½ÃÇè<<¾Æ½ºÄÚ¸£ºó»ê½ÃÇè>>
  • CPT=£¾cold pressure test
    ³Ã¾Ð¹Ú½ÃÇè.
  • Callaways test
    Ķ·¯¿þÀ̽ÃÇè.
  • Carr-Price test
    Ä«¾Æ-ÇÁ¶óÀ̽º½ÃÇè.
  • Cartwright test
    īƮ¶óÀÌÆ®½ÃÇè
  • Casamajors test
    Ä«»ç¸ÞÁ¶¸£½ÃÇè.
  • Chapmans test
    Â÷ÇÁ¸¸½ÃÇè.
  • Charlton blanching test
    »þ¸¦Åæ½ÃÇè.
  • Chautards test
    ¼îŸ¸£½ÃÇè.
  • Cherry-randall test
    ü¸®-Å©¶õ´Þ½ÃÇè.
  • Chido test
    Chido ½ÃÇè
  • Chopras test
    ¼îÇÁ¶ó°Ë»ç.
  • Congo red test
    Äá°íÀû½ÃÇè.»ýÈ­Äá°í·¹µå½ÃÇè.
  • Continuous Performance Test
    Áö¼Ó¼öÇà °Ë»ç
  • Coombs consumption test
    Äñ½º¼Ò¸ð°Ë»ç
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
  • skin reaction
    ÇǺιÝÀÀ(¡­Úãëë)
  • skin reaction
    ÇǺιÝÀÀ
  • skin reaction
    ÇǺιÝÀÀ(¡­Úãëë).
  • skin reactive factor (SRF)
    ÇǺιÝÀÀÀÎÀÚ
  • skin reflex
    ÇǺιݻç(¡­ÚãÞÒ).
  • skin retinacula
    ÇǺÎÁöÁö¶ì
  • skin ridge
    ÇǺδɼ±
  • skin scraping
    ÇǺÎÂû°ú
  • skin sensitization
    ÇǺΰ¨ÀÛ
  • skin sensitizing antibody
    ÇǺΰ¨ÀÛ¼º Ç×ü(¡­ÊïíÂàõù÷ô÷).
  • skin smear
    ÇǺεµ¸»°Ë»ç
  • skin softener
    ÇǺο¬È­Á¦
  • skin softeners
    ÇǺο¬È­Á¦.
  • skin sparing
    ÇǺκ¸Á¸
  • skin sparing effect
    ÇǺκ¸È£È¿°ú(¡­ÜÁûÞüùÍý).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
TT tablet triturate; tactile tension; tendon transfer; test tube; testicular torsion; tetanus toxin; te...
TTT thymol turbidity test; tolbutamide tolerance test; total twitch time; tuberculin tine test
VAT variable antigen type; ventricular accommodation test; ventricular activation time; vesicular amine ...
DTIC Dimethyl Triazeno Imidazole Carboxamide
  ; Alkylating Agent
HDV Hepatitis D(elta) Virus
  = HBV associated Delta Agent
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 9
SKALP Skin-derived antileucoproteinase
SSSS Staphylococcal Scalded Skin Syndrome
SSR Sympathetic Skin Response
TST Tail skin temperature
TSK Tight Skin
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • paramagnetic agent
    »óÀÚ¼º Á¦Àç
  • potassium-sparing agent

    potency

    ÀáÀç´É, ÀáÀç·Â, È¿·Â, ¿ª°¡
  • protective agent
    º¸È£ ¾à, ÇÇÆ÷ ¾à
  • psychedelic agent
    ȯ°¢Á¦
  • radioopaque agent
    ¹æ»ç¼± ºÒÅõ°ú¼º Á¦Àç, ¹æ»ç¼± ºñÅõ°ú¼º Á¦Àç
    ¹°¸®Àû, È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • radioprotective agent
    ¹æ»ç¼± ¹æ¾îÁ¦
    ¹°¸®Àû È­ÇÐÀû ¶Ç´Â »ý¹°ÇÐÀûÀÎ È¿°ú¸¦ ÀÏÀ¸Å°´Â Èû, ¼ººÐ ¶Ç´Â ¹°Áú.
  • radiosensitive agent
    ¹æ»ç¼±Áõ Á¦¾à
    X¼± ¶Ç´Â ±âŸ ´Ù¸¥ ¹æ»ç¼± ¿¡³ÊÁö¿¡ ´ëÇÑ °¨¼ö¼ºÀ» Áõ°­½ÃŰ´Â ¾à¹°.
  • receptor blocking agent
    ¼ö¿ëü Â÷´ÜÁ¦
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø ¹°Áú
  • sclerosing agent
    °æÈ­ ¾à, °æÈ­Á¦
  • silane coupling agent
    ½Ç¶õÄ¿ÇÁ¸µÁ¦
    ±âÀç¿Í ÇÊ·¯ÀÇ »çÀÌ¿¡ À־ ¾çÀÚ¸¦ È­ÇÐÀûÀ¸·Î °áÇÕÇϰí Á¢Âø È¿°ú¸¦ ³ôÀ̴µ¥ »ç¿ëµÇ´Â ½Ç¶õÁ¦.
  • spermicidal agent
    »ìÁ¤Á¦
  • sympathetic blocking agent
    ±³°¨½Å°æ ºÀ¼âÁ¦, ±³°¨½Å°æ Â÷´ÜÁ¦
  • sympatholytic agent
    ±³°¨½Å°æ ¾ïÁ¦Á¦
    ±³°¨½Å°æÀÇ ÀÛ¿ëÀ» ¾ïÁ¦ÇÏ´Â ¾à. ±³°¨½Å°æ ÈïºÐÁ¦¿Í ±æÇ×ÇÑ´Ù. ÀÌ ¾àÀº ´ÙÀ½°ú °°Àº Á¾·ùÀÇ °ÍÀÌ Æ÷ÇԵǴµ¥, ¨ç Ä«Å×ÄݾƹÎ
  • sympathomimetic agent
    ±³°¨½Å°æ ÈïºÐÁ¦
    ±³°¨½Å°æÀÌ ÈïºÐÇßÀ» ¶§¿Í °°Àº ÀÛ¿ëÀ» ³ªÅ¸³»°Ô ÇÏ´Â ¾à. ±³°¨½Å°æÀÌ ÈïºÐÇßÀ» ¶§ ü³»¿¡´Â Ä«Å×ÄݾƹÎ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 9
skin cancer <oncology> A malignant growth on the skin.
Risk factors include: those who are fair-skinned or sunburn easily, freckled skin, blue or green eyes, blond or red hair, multiple moles, multiple bad sunburns in the past (particularly as a child) and a prior history for a skin cancer.
(27 Sep 1997)
skin care Maintenance of the hygienic state of the skin under optimal conditions of cleanliness and comfort. Effective in skin care are proper washing, bathing, cleansing, and the use of soaps, detergents, oils, etc. In various disease states, therapeutic and protective solutions and ointments are useful. The care of the skin is particularly important in various occupations, in exposure to sunlight, in neonates, and in decubitus ulcer.
(12 Dec 1998)
skin-deep Not deeper than the skin; hence, superficial.
Source: Websters Dictionary
(01 Mar 1998)
skin diseases, bacterial Skin diseases caused by bacteria.
(12 Dec 1998)
skin diseases, eczematous Any of a variety of eruptive skin disorders characterised by erythema, oozing, vesiculation, and scaling. Aetiology is varied.
(12 Dec 1998)
skin diseases, genetic Diseases of the skin with a genetic component, usually the result of various inborn errors of metabolism.
(12 Dec 1998)
skin diseases, infectious Skin diseases caused by bacteria, fungi, parasites, or viruses.
(12 Dec 1998)
skin diseases, metabolic Diseases of the skin associated with underlying metabolic disorders.
(12 Dec 1998)
skin diseases, papulosquamous A group of dermatoses with distinct morphologic features. The primary lesion is most commonly a papule, usually erythematous, with a variable degree of scaling on the surface. Plaques form through the coalescing of primary lesions.
(12 Dec 1998)
skin diseases, parasitic Skin diseases caused by arthropods, helminths, or protozoa.
(12 Dec 1998)
skin diseases, vascular Skin diseases affecting or involving the cutaneous blood vessels and generally manifested as inflammation, swelling, erythema, or necrosis in the affected area.
(12 Dec 1998)
skin diseases, vesiculobullous Skin diseases characterised by local or general distributions of blisters. They are classified according to the site and mode of blister formation. Lesions can appear spontaneously or be precipitated by infection, trauma, or sunlight. Aetiologies include immunologic and genetic factors.
(12 Dec 1998)
skin diseases, viral Skin diseases caused by viruses.
(12 Dec 1998)
skin dose The quantity of radiation delivered to the skin surface.
(05 Mar 2000)
skin flap A flap comprised of skin and its subjacent subcutaneous tissue.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 9
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 9
ÅëÇÕ°Ë»ö ¿Ï·á